Dfine, a developer of minimally invasive radiofrequency (RF) targeted therapies for the treatment of vertebral pathologies, will debut the STAR Tumor Ablation System at the Society of Interventional Radiology's (SIR) 37th Annual Scientific Meeting in San Francisco.
The STAR System is a targeted procedure and minimally invasive for rapid pain relief, compatible with current treatment algorithms, and offers an alternative for patients who have reached their cumulative toxicity limit.
It can potentially treat radio-resistant lesions and reduce pain prior to radiotherapy, the company said.
DFINE chief executive officer Kevin Mosher said the STAR System, using targeted radiofrequency ablation (t-RFA), will be used in the palliative treatment of patients suffering from the debilitating effects of spinal tumors within the vertebral body.
"It improves the physician’s ability to offer acute pain relief through the use of a single, minimally invasive procedure that is compatible with both chemotherapy and radiation therapy," Mosher said.